ABT-518 is an inhibitor of matrix metalloproteinases, which are associated with tumor growth and development of metastasis. References: Fattori D, Squarcia A, Bartoli S. Fragment-based approach to drug lead discovery: overview and advances in various techniques. Drugs R D. 2008;9(4):217-27. Review. PubMed PMID: 18588353.

纯度：≥98%

CAS：286845-00-9